Skip to content
lifestyle.celebhomes.net
Home
Sample Page
Author:
Alveus Therapeutics Inc
Alveus Therapeutics Announces FDA Clearance of IND and First Patient Dosed in Phase 1b Trial of ALV-100 for Obesity
January 23, 2026